Pathophysiology and management of neuropsychiatric symptoms in succinic semialdehyde dehydrogenase deficiency

Psychiatr Genet. 2021 Jun 1;31(3):100-101. doi: 10.1097/YPG.0000000000000277.

Authors

Sachin Phakey¹, Mark Walterfang^{1

2

3}

Affiliations

¹ Neuropsychiatry Unit, Royal Melbourne Hospital.
² Department of Psychiatry.
³ Melbourne Neuropsychiatry Centre, University of Melbourne, Victoria, Australia.

PMID: 33953124
DOI: 10.1097/YPG.0000000000000277

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Amino Acid Metabolism, Inborn Errors / physiopathology*
Amino Acid Metabolism, Inborn Errors / psychology
Antipsychotic Agents / therapeutic use
Developmental Disabilities / physiopathology*
Developmental Disabilities / psychology
Female
Humans
Mental Disorders / drug therapy*
Succinate-Semialdehyde Dehydrogenase / deficiency*

Substances

Antipsychotic Agents
Succinate-Semialdehyde Dehydrogenase

Supplementary concepts

succinic semialdehyde dehydrogenase deficiency